Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122264412 | 12226441 | 2 | F | 20160627 | 20160331 | 20160711 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-18696BP | BOEHRINGER INGELHEIM | 0.00 | F | Y | 0.00000 | 20160711 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122264412 | 12226441 | 1 | PS | MOBIC | MELOXICAM | 1 | Unknown | U | 20938 | ||||||||||
| 122264412 | 12226441 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 300 MG | U | 0 | 100 | MG | CAPSULE | TID | |||||
| 122264412 | 12226441 | 3 | SS | NEURONTIN | GABAPENTIN | 1 | Unknown | U | 0 | ||||||||||
| 122264412 | 12226441 | 4 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 122264412 | 12226441 | 5 | SS | BACITRACIN STERILE | BACITRACIN | 1 | Unknown | STRENGTH: 500UNIT/GRAM, FORMULATION: EYE OINTMENT | U | 0 | |||||||||
| 122264412 | 12226441 | 6 | SS | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG | U | 0 | 40 | MG | TABLET | QD | |||||
| 122264412 | 12226441 | 7 | SS | XANAX | ALPRAZOLAM | 1 | Oral | STRENGTH: 0.5MG; DOSE PER APPLICATION AND DAILY DOSE: 1 1/2 TABLET EVERY 8 HOURS | U | 0 | TABLET | Q8H | |||||||
| 122264412 | 12226441 | 8 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG | 0 | 40 | MG | QD | |||||||
| 122264412 | 12226441 | 9 | C | ALBUTEROL SULFATE. | ALBUTEROL SULFATE | 1 | Unknown | 12 ML | 0 | 3 | ML | QID | |||||||
| 122264412 | 12226441 | 10 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
| 122264412 | 12226441 | 11 | C | BETAMETHASONE DIPROPIONATE. | BETAMETHASONE DIPROPIONATE | 1 | Topical | STRENGTH: 0.05 %, DOSE PER APPLICATION AND DAILY DOSE: FEW DROPS | 0 | QD | |||||||||
| 122264412 | 12226441 | 12 | C | BUTALBITAL-ACETAMINOPHEN | 2 | Oral | DOSE PER APPLICATION: 50MG-325MG 1-2 TABLETS | 0 | TABLET | ||||||||||
| 122264412 | 12226441 | 13 | C | CALCIUM | CALCIUM | 1 | Unknown | 500 MG | 0 | 500 | MG | CAPSULE | QD | ||||||
| 122264412 | 12226441 | 14 | C | CARAFATE | SUCRALFATE | 1 | Oral | 5 G | 0 | 1 | G | TABLET | |||||||
| 122264412 | 12226441 | 15 | C | COENZYME Q10 | UBIDECARENONE | 1 | Unknown | RED YEAST RICE, DOSE PER APPLICATION AND DAILY DOSE: 60MG-600MG | 0 | CAPSULE | BID | ||||||||
| 122264412 | 12226441 | 16 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MG | 0 | 1 | MG | TABLET | QD | ||||||
| 122264412 | 12226441 | 17 | C | KLOR-CON M20 | POTASSIUM CHLORIDE | 1 | Oral | 1 ANZ | 0 | QD | |||||||||
| 122264412 | 12226441 | 18 | C | LASIX | FUROSEMIDE | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 122264412 | 12226441 | 19 | C | LORATADINE. | LORATADINE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 122264412 | 12226441 | 20 | C | MAXZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Oral | 1 ANZ | 0 | TABLET | QD | ||||||||
| 122264412 | 12226441 | 21 | C | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 2.5 ANZ | 0 | TABLET | QOD | ||||||||
| 122264412 | 12226441 | 22 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 122264412 | 12226441 | 23 | C | NIACIN. | NIACIN | 1 | Oral | 1000 MG | 0 | 1000 | MG | TABLET | QD | ||||||
| 122264412 | 12226441 | 24 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Oral | 400 MG | 0 | 200 | MG | TABLET | BID | ||||||
| 122264412 | 12226441 | 25 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 122264412 | 12226441 | 26 | C | PYRIDIUM | PHENAZOPYRIDINE | 1 | Oral | 120 MG | 0 | 40 | MG | TABLET | TID | ||||||
| 122264412 | 12226441 | 27 | C | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 6 MG | 0 | 3 | MG | TABLET | BID | ||||||
| 122264412 | 12226441 | 28 | C | RHINOCORT AQUA | BUDESONIDE | 1 | Nasal | 1 ANZ | 0 | QD | |||||||||
| 122264412 | 12226441 | 29 | C | SOMA | CARISOPRODOL | 1 | Oral | 1400 MG | 0 | 350 | MG | TABLET | Q6H | ||||||
| 122264412 | 12226441 | 30 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 400 MG | 0 | 100 | MG | TABLET | Q6H | ||||||
| 122264412 | 12226441 | 31 | C | VALIUM | DIAZEPAM | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | |||||||
| 122264412 | 12226441 | 32 | C | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | 90MCG/ACTUATION | 0 | INHALATION SOLUTION | ||||||||||
| 122264412 | 12226441 | 33 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 2000 U | 0 | 2000 | IU | CAPSULE | QD | ||||||
| 122264412 | 12226441 | 34 | C | VITAMIN E 400 | 2 | Unknown | 400 U | 0 | 400 | IU | TABLET | ||||||||
| 122264412 | 12226441 | 35 | C | ZOMIG | ZOLMITRIPTAN | 1 | Other | ROUTE: TRANSINGUAL | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122264412 | 12226441 | 1 | Product used for unknown indication |
| 122264412 | 12226441 | 2 | Product used for unknown indication |
| 122264412 | 12226441 | 3 | Product used for unknown indication |
| 122264412 | 12226441 | 4 | Product used for unknown indication |
| 122264412 | 12226441 | 5 | Product used for unknown indication |
| 122264412 | 12226441 | 6 | Product used for unknown indication |
| 122264412 | 12226441 | 7 | Product used for unknown indication |
| 122264412 | 12226441 | 8 | Product used for unknown indication |
| 122264412 | 12226441 | 9 | Product used for unknown indication |
| 122264412 | 12226441 | 10 | Product used for unknown indication |
| 122264412 | 12226441 | 11 | Product used for unknown indication |
| 122264412 | 12226441 | 12 | Product used for unknown indication |
| 122264412 | 12226441 | 13 | Product used for unknown indication |
| 122264412 | 12226441 | 14 | Product used for unknown indication |
| 122264412 | 12226441 | 15 | Product used for unknown indication |
| 122264412 | 12226441 | 16 | Product used for unknown indication |
| 122264412 | 12226441 | 17 | Product used for unknown indication |
| 122264412 | 12226441 | 18 | Product used for unknown indication |
| 122264412 | 12226441 | 19 | Product used for unknown indication |
| 122264412 | 12226441 | 20 | Product used for unknown indication |
| 122264412 | 12226441 | 21 | Product used for unknown indication |
| 122264412 | 12226441 | 22 | Product used for unknown indication |
| 122264412 | 12226441 | 23 | Product used for unknown indication |
| 122264412 | 12226441 | 24 | Product used for unknown indication |
| 122264412 | 12226441 | 25 | Product used for unknown indication |
| 122264412 | 12226441 | 26 | Product used for unknown indication |
| 122264412 | 12226441 | 27 | Product used for unknown indication |
| 122264412 | 12226441 | 28 | Product used for unknown indication |
| 122264412 | 12226441 | 29 | Product used for unknown indication |
| 122264412 | 12226441 | 30 | Product used for unknown indication |
| 122264412 | 12226441 | 31 | Product used for unknown indication |
| 122264412 | 12226441 | 32 | Product used for unknown indication |
| 122264412 | 12226441 | 33 | Product used for unknown indication |
| 122264412 | 12226441 | 34 | Product used for unknown indication |
| 122264412 | 12226441 | 35 | Headache |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122264412 | 12226441 | Anxiety | |
| 122264412 | 12226441 | Fibromyalgia | |
| 122264412 | 12226441 | Restless legs syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122264412 | 12226441 | 5 | 20160512 | 0 |